Abstract
COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARSCoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests that investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities.
Original language | English |
---|---|
Pages (from-to) | 265-267 |
Number of pages | 3 |
Journal | Journal of Infection in Developing Countries |
Volume | 14 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2020 |
Bibliographical note
Funding Information:We are grateful to Emanuela Sias, Gabriele Carenti, and Esmeralda Ughi for their valuable assistance. This work was supported by the Li-Ka Shing Foundation, Shantou University Medical College; a Rapid Response award for COVID-19, Canadian Institutes of Health Research (DJK and SR); Dalhousie Medical Research Foundation; and a Rapid Response Award from Research Nova Scotia. DJK holds the Canada Research Chair in Translational Vaccinology and Inflammation.
Publisher Copyright:
Copyright © 2020 Rubino et al.
ASJC Scopus Subject Areas
- Parasitology
- Microbiology
- Infectious Diseases
- Virology
PubMed: MeSH publication types
- Journal Article